India's Ipca Labs jumps to record high after co upgrades FY27 guidance
BUZZ-India's Ipca Labs jumps to record high after co upgrades FY27 guidance ** Shares of India's Ipca Labs IPCA.NS rise as much as 12.16% to record high of 1945.10 rupees; last up 6.8%
** Pharma co upgraded guidance for FY27 revenue growth to 14-16% from 12-13% earlier; eight brokerages raise TP
** PhillipCapital ("neutral", PT 1800 rupees) says exports will continue to benefit from favourable currency dynamics and steady progress in US business
** Emkay Global ("buy", PT 1950 rupees) says co's Q1 performance eases concerns about standalone margins as well as unit Unichem's margins
** Adds, co's structural domestic volume growth ahead of peers on a 4-year CAGR basis
** More than 4.3 mln shares change hands by 11:40 am IST, 15 times the 30-day avg
** Stock rated "buy" on avg by 15 analysts; median PT is 1870 rupees -- LSEG-compiled data
** Stock up 30.6% YTD
(Reporting by Abhirami G in Bengaluru)
Recent news on Ipca Laboratories
See all newsBrief: IPCA Labs Sept-Quarter Consol Net PAT 3.75 Billion Rupees
India's Ipca Labs jumps to record high after co upgrades FY27 guidance
Brief: IPCA Labs June-Quarter Consol Net Profit 4.02 Billion Rupees
Brief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees